Similar Articles
1721 Genetic alterations of hepatocellular carcinoma by random amplified polymorphic DNA analysis and cloning sequencing of tumor differential DNA fragment
1722 Diagnostic laparoscopy and laparoscopic ultrasonography with local anesthesia in hepatocellular carcinoma
1723 Expression and significance of new inhibitor of apoptosis protein survivin in hepatocellular carcinoma
1724 5-Fluorouracil concentration in blood, liver and tumor tissues and apoptosis of tumor cells after preoperative oral 5’-deoxy-5-fluorouridine in patients with hepatocellular carcinoma
1725 Somatostatin receptor subtype 2-mediated scintigraphy and localization using 99mTc-HYNIC-Tyr3-octreotide in human hepatocellular carcinoma-bearing nude mice
1726 Surgical treatment of hepatocellular carcinoma with bile duct tumor thrombi
1727 Successful management of postoperative recurrence of hepatocellular carcinoma with p53 gene therapy combining transcatheter arterial chemoembolization
1728 Inhibitory effect of adeno-associated virus-mediated gene transfer of human endostatin on hepatocellular carcinoma
1729 Pivotal molecules of MHC I pathway in human primary hepatocellular carcinoma
1730 Mismatch repair genes (hMLH1, hPMS1, hPMS2, GTBP/hMSH6, hMSH2) in the pathogenesis of hepatocellular carcinoma
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA